Global Custom Market Research Reports Provider Company

phone

Vascular Biogenics Ltd (VBLT) - Financial and Strategic SWOT Analysis Review

  • Published Date: 13 Nov 2017
  • Number of Pages: 25
  • Category: Healthcare and Medical
  • Country: Israel
Summary

Vascular Biogenics Ltd (VBL) is a clinical biopharmaceutical company that discovers, develops and commercializes treatments for cancer. The companys product pipeline includes VB-111. Its product VB-111 is an anti-angiogenic agent for the specific inhibition of tumor vascular growth for cancer therapy. VBL also administers treatment for solid tumor indications, with clinical trials in rGBM, thyroid cancer and ovarian cancer. The company designs its product to address oncology indications in solid tumors, by the blood vessels required for tumor growth. It develops a proprietary platform of designated Lecinoxoids, orally-available small molecules for the treatment of chronic immune-related indications. The company also developed programs based proprietary platform technologies including an oncology program and an anti-inflammatory program. VBL is headquartered in Or Yehuda, Israel.

Vascular Biogenics Ltd Key Recent Developments

Aug 14,2017: VBL Therapeutics Announces Second Quarter 2017 Financial Results
Jun 15,2017: VBL Therapeutics Announces Appointment of Dr. Corinne Epperly as U.S. Chief Operating Officer
May 15,2017: VBL Therapeutics Announces First Quarter 2017 Financial Results
Aug 15,2016: VBL Therapeutics Announces Second Quarter 2016 Financial Results and Provides Business Update
Jun 22,2016: VBL Therapeutics announces appointment of Dr. Rachel W. Humphrey to head of the Scientific Advisory Board

This comprehensive SWOT profile of Vascular Biogenics Ltd provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalDatas Profile on Demand service, covering over 50,000 of the worlds leading companies. Once purchased, GlobalDatas highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Vascular Biogenics Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,



- Business description A detailed description of the companys operations and business divisions.

- Corporate strategy Analysts summarization of the companys business strategy.

- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.

- Company history Progression of key events associated with the company.

- Major products and services A list of major products, services and brands of the company.

- Key competitors A list of key competitors to the company.

- Key employees A list of the key executives of the company.

- Executive biographies A brief Summary of the executives employment history.

- Key operational heads A list of personnel heading key departments/functions.

- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.



Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,



You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.



Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.



Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.



Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.



Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Publisher Name : GlobalData
Table of Contents


Section 1 - About the Company



Vascular Biogenics Ltd - Key Information

Vascular Biogenics Ltd - Overview

Vascular Biogenics Ltd - Key Employees

Vascular Biogenics Ltd - Key Employee Biographies

Vascular Biogenics Ltd - Key Operational Heads

Vascular Biogenics Ltd - Major Products and Services

Vascular Biogenics Ltd - History

Vascular Biogenics Ltd - Company Statement

Vascular Biogenics Ltd - Locations And Subsidiaries

Vascular Biogenics Ltd - Key Manufacturing facilities

Head Office

Other Locations & Subsidiaries



Section 2 - Company Analysis



Vascular Biogenics Ltd - Business Description

Vascular Biogenics Ltd - Corporate Strategy

Vascular Biogenics Ltd - SWOT Analysis

SWOT Analysis - Overview

Vascular Biogenics Ltd - Strengths

Vascular Biogenics Ltd - Weaknesses

Vascular Biogenics Ltd - Opportunities

Vascular Biogenics Ltd - Threats

Vascular Biogenics Ltd - Key Competitors



Section 3 - Company Financial Performance Charts



Vascular Biogenics Ltd - Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts



Section 4 - Appendix



Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer





Note*: Some sections may be missing if data is unavailable for the company

List Of Tables




Vascular Biogenics Ltd, Key Information

Vascular Biogenics Ltd, Key Ratios

Vascular Biogenics Ltd, Share Data

Vascular Biogenics Ltd, Major Products and Services

Vascular Biogenics Ltd, History

Vascular Biogenics Ltd, Key Employees

Vascular Biogenics Ltd, Key Employee Biographies

Vascular Biogenics Ltd, Key Operational Heads

Vascular Biogenics Ltd, Other Locations

Vascular Biogenics Ltd, Subsidiaries

Vascular Biogenics Ltd, Key Manufacturing facilities

Vascular Biogenics Ltd, Key Competitors

Vascular Biogenics Ltd, SWOT Analysis

Vascular Biogenics Ltd, Ratios based on current share price

Vascular Biogenics Ltd, Annual Ratios

Vascular Biogenics Ltd, Interim Ratios

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List Of Figures




Vascular Biogenics Ltd, Performance Chart

Vascular Biogenics Ltd, Ratio Charts

In this report, the United States Cardiovascular Agents market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022,

View Report

In this report, the United States Intravascular Imaging System market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of

View Report

In this report, the United States Vascular Closure Systems market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports